Cardiac device infection: diagnosis, extraction and reimplantation
Infection of cardiac implantable electronic devices (CIEDs) can affect a pacemaker, implantable cardioverter-defibrillator, cardiac resynchronisation therapy device or subcutaneous defibrillator. It may remain confined to a generator pocket or extend along transvenous leads, producing bacteraemia, tricuspid involvement or infective endocarditis. Biofilm makes the problem more than a simple wound infection.
Clinical signs can be subtle, particularly in older adults and people with diabetes or immunosuppression. A pocket may be erythematous, tender, fluctuant or discharging, while systemic disease may present as fever, rigors, weight loss, embolic phenomena or unexplained heart failure. Previous surgery, immunosuppression, dialysis and repeated device manipulation increase risk.
Management requires coordinated input from electrophysiology, infectious diseases, microbiology, imaging and, when needed, cardiac surgery. The goals are to control sepsis, remove infected hardware, identify the organism and restore safe pacing or defibrillation without compromising future vascular access.
Recognising pocket infection and systemic disease
Red flags include new erythema over a pulse-generator pocket, purulent drainage, wound dehiscence, exposed hardware or erosion. Fever or positive blood cultures should prompt a search for an implanted device, including in patients whose apparent infection source is unclear. Pocket erythema alone can be non-infective, so serial examination and device-focused assessment matter.
The clinical pattern should be separated into local pocket infection, bloodstream infection without endocarditis, lead-associated infection and CIED-related endocarditis. Tricuspid regurgitation, pulmonary emboli, vertebral osteomyelitis and persistent bacteraemia suggest deeper involvement. Device infection can also cause relapsing infection after apparently successful treatment, especially when infected material remains.
Diagnosing device and bloodstream involvement
Device interrogation should review interrogation notes, sensing, capture thresholds, impedance trends, arrhythmia history and unexpected resetting or noise. These findings may support suspicion but do not exclude infection, and interrogation must not delay urgent management of sepsis or obvious pocket infection. Subcutaneous devices require particular attention to pocket findings because they have no transvenous lead.
When bacteraemia is possible, obtain three sets of peripheral blood cultures before antibiotics if the patient is stable; do not delay antibiotics in septic shock. Collect specimens from separate peripheral sites, not routinely through the device. Pocket drainage or discharge should be sampled where material is available, and all relevant cultures should be sent with clear device and antibiotic history.
At extraction, pocket tissue, lead tips and, when feasible, explanted generator components should be cultured. Sonication of explanted leads can improve organism recovery where laboratory expertise exists, although negative culture results do not rule out infection. Coagulase-negative staphylococci, Staphylococcus aureus, enterococci, gram-negative organisms and Candida species are all clinically relevant, with susceptibility testing essential for targeted treatment.
Imaging the infection and defining its extent
Transthoracic echocardiography is a useful first study for vegetations, tricuspid involvement and haemodynamic consequences, but it can miss small device-associated lesions. Transoesophageal echocardiography offers greater sensitivity for lead and valvular vegetations and is particularly useful when bacteraemia persists, the patient has prosthetic material or routine echocardiography is discordant with the clinical picture.
Computed tomography angiography can define venous anatomy, abscesses, pocket collections and destructive mediastinal or cardiac involvement. Radiolabelled white-cell imaging may occasionally clarify an occult infection. FDG-PET/CT can show inflammation around a generator or leads and identify metastatic foci, but uptake is not perfectly specific. Imaging should answer a management question rather than replace cultures and clinical judgement.
Extraction indications and procedural planning
Complete removal of the generator and all transvenous leads, including previously abandoned leads when feasible, is usually indicated for pocket erosion, persistent bacteraemia, CIED-related endocarditis, or infection caused by S aureus, enterococci or fungi. Large vegetations, recurrent pulmonary emboli and failure to clear organisms with appropriate treatment strengthen the case. In some bacteraemic cases without these features, multidisciplinary review is required rather than automatic extraction.
Lead removal may use manual traction, powered extraction tools, a laser sheath or an electrosurgical sheath. Surgical or endoscopic support is needed when standard approaches fail, the lead is firmly embedded, major cardiac or vascular injury occurs, or simultaneous cardiac surgery is required. The operator must be experienced because the infected field may be friable and the myocardium or tricuspid valve can be injured.
Procedural planning includes blood cultures, anticoagulation assessment, anaesthetic review, access to echocardiography, temporary pacing and blood products. Surgical backup and intensive care support are essential for complex cases. The team should anticipate tamponade, vascular perforation, severe tricuspid injury, arrhythmia and bleeding, and should document the planned device-removal strategy before the procedure.
Antimicrobial therapy and multidisciplinary care
Empiric therapy should be selected promptly after cultures, using the local antibiogram, likely organisms, prior antibiotics, healthcare exposure and the severity of illness. Common empiric regimens include vancomycin with an appropriate antipseudomonal agent for unstable or healthcare-associated infection, then narrow as susceptibility data become available. Antifungal treatment may be required for Candida or other invasive fungal infection.
Antibiotic duration depends on the site, organism, bacteraemia, vegetations, metastatic foci and response. Pocket infection without systemic involvement may require a shorter course than CIED-related endocarditis, while persistent bacteraemia or untreated infected material usually makes prolonged therapy and complete extraction necessary. Infectious-disease input is particularly valuable for unusual organisms, resistant isolates and suspected persistent infection.
Supportive care includes fever control, fluid replacement, nutrition, renal monitoring and treatment of competing infections. Follow-up should combine blood cultures where appropriate, inflammatory markers, wound review, repeat echocardiography and device-clinic assessment. A staged plan should connect extraction, antimicrobial delivery and eventual reimplantation so that treatment gaps are not created by fragmented outpatient follow-up.
Reimplantation after infection control
Reimplantation should occur only after the infection is clinically controlled, organisms have cleared when bacteraemia was present, and sufficient antimicrobial therapy has been delivered. There is no universal waiting period. Selected stable patients may be reimplanted during the same admission, while endocarditis, persistent inflammation or delayed clinical response usually justify staged treatment.
The same-side and contralateral approaches each have trade-offs. Reusing the pocket and ipsilateral veins can preserve access for a future lead upgrade, but may be unsuitable when tissue is contaminated, necrotic or extensively dissected. Contralateral implantation offers a clean pocket and can be prudent after pocket erosion, yet it consumes another venous route and may complicate cardiac resynchronisation therapy or lead length. Patient age, anticoagulation, renal function, vascular anatomy and future device needs should guide the decision.
Device selection should match the original indication for pacing, defibrillation or resynchronisation, while accounting for infection risk, comorbidities and available lead options. In patients with limited venous access, pre-extraction venography and a clear contingency for alternative access are important. Where conduction-system pacing may form part of a revised strategy, the His-Purkinje pacing update provides useful technical context, although pacing choice does not replace infection-control principles.
Adaptation to Australian practice
Australian care is delivered through public and private hospital systems, with complex infections concentrated in tertiary referral networks in Sydney, Melbourne and Brisbane. Regional hospitals and rural clinicians often identify the infection first and coordinate transfer to a centre with electrophysiology, infectious-disease, imaging and surgical support. Some follow-up can be delivered by telehealth, but device assessment, wound review and cultures still require timely local care.
Medicare covers eligible inpatient procedures through public hospitals and Medicare benefit arrangements, while private insurance and hospital contracts affect the split between insurer-funded and out-of-pocket costs. This matters for patients who need prolonged IV therapy, repeated imaging, surgery and new hardware. Clinicians should also discuss the burdens of transport, accommodation and missed work, particularly for families travelling from regional or remote areas.
The Therapeutic Goods Administration and Australian Register of Therapeutic Goods govern the approval and supply of eligible implantable cardiac devices, and hospital procurement depends on local distributor networks and stock. When explanted hardware is sent overseas for manufacturer analysis, export documentation and Australian Customs clearance may be required; an extracted unit remains contaminated waste and must never return to implant stock. The journal profile describes the publication's scope, open-access model and society affiliations for readers seeking current evidence.
Facing a suspected CIED infection, use a structured pathway: cultures, device review, focused imaging, early specialist involvement and a clear extraction and reimplantation plan. Prompt source control remains central when infection is established, while careful device selection protects pacing and defibrillation needs after treatment.
Clinicians, trainees and patients can browse latest research to access peer-reviewed research, reviews and themed collections, then apply the evidence within local protocols and individual clinical circumstances.